Clinical Trial Details
EORTC-40051
Back to Clinical Trials Database
Randomized phase II trial evaluating the feasibility and tolerance of the combination of FOLFOX with cetuximab and the combination of FOLFOX with cetuximab and bevacizumab as perioperative treatment in patients with resectable liver metastases from colorectal cancer (BOS).
| Trial Status | All trial activities ended |
|---|---|
| Dates |
Date of activation: 04-Jan-2007 Date Step1 close: 12-Jun-2009 |
| Data management at EORTC | Yes |
| Design |
Phase 2 Randomized open label |
| Targeted Sample size | EORTC Groups: 100 - All Groups: 100 |
| Treatment | |
| Study Staff | |
| Type of cancer | |
| Participating groups | |
| Protocol summary | http://clinicaltrials.gov/study/NCT00438737 |
| NCT number | NCT00438737 |
| EudraCT | 2005-002825-29 |
